Vivtex was founded by GIOVANNI TRAVERSO, THOMAS VON ERLACH, Thomas von Erlach in 2018.

Who are Vivtex's investors?

Vivtex's investors include Portal Innovations.

How much funding has Vivtex raised?

Vivtex has disclosed $1.8M raised across 1 round.

Where is Vivtex headquartered?

Vivtex is headquartered in Cambridge, US.

Vivtex

Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors

vivtex.com ↗

Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines. It operates in the biotech/therapeutics space, working on drug development and related laboratory research.

AI & Machine LearningBiotechDeep TechMedical Devices

Founders & leadership

Vivtex was founded in 2018 by GIOVANNI TRAVERSO, THOMAS VON ERLACH, and Thomas von Erlach.

GIOVANNI TRAVERSOCo-founder

THOMAS VON ERLACHCo-founder

Thomas von ErlachCEO & Co-founder

JAMES WINSCHELNamed on SEC filing

JUAN LOPEZNamed on SEC filing

ROBERT LANGERNamed on SEC filing

JACQUES BARBUTNamed on SEC filing

JAMES WRIGHTNamed on SEC filing

Robert LangerCo-founder

Giovanni TraversoCo-founder

Investors · 1

Portal InnovationsChicago

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 1 round · 2022

▶$1.8MraisedAug 2022 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

GIOVANNI TRAVERSODirector
JAMES WINSCHELExecutive Officer, Director
JUAN LOPEZExecutive Officer
ROBERT LANGERDirector
JACQUES BARBUTDirector
JAMES WRIGHTExecutive Officer
THOMAS VON ERLACHExecutive Officer, Director

Offering amount: $1.8M
Amount sold: $1.8M
First sale: May 2022
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

EquityZen9 shared keywords

Vivace Therapeutics9 shared keywordsVivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types. The company adopts a capital-efficient approach to advance novel cancer therapeutics, with potential applications also in fibrotic disease.

Companies competing with Vivtex for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Vivtex do?: Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines. It operates in the biotech/therapeutics space, working on drug development and related laboratory research.
Who founded Vivtex?: Vivtex was founded by GIOVANNI TRAVERSO, THOMAS VON ERLACH, Thomas von Erlach in 2018.
Who are Vivtex's investors?: Vivtex's investors include Portal Innovations.
How much funding has Vivtex raised?: Vivtex has disclosed $1.8M raised across 1 round.
Where is Vivtex headquartered?: Vivtex is headquartered in Cambridge, US.